InvestorsHub Logo
Followers 3157
Posts 962073
Boards Moderated 182
Alias Born 09/04/2000

Re: Purple Wonder post# 5745

Friday, 08/07/2020 11:39:14 AM

Friday, August 07, 2020 11:39:14 AM

Post# of 6735
$ABUS Arbutus Reports Second Quarter 2020 Financial Results and Provides Corporate Update

https://finance.yahoo.com/news/arbutus-reports-second-quarter-2020-113000595.html

GlobeNewswire
Arbutus Biopharma Corporation
,GlobeNewswire•August 7, 2020
Phase 1a/1b clinical trial for AB-729, a subcutaneously delivered RNAi agent, remains on track with results from additional cohorts expected in the second half of 2020

AB-836, an oral capsid inhibitor, remains on track for completion of IND enabling studies by the end of 2020

Actively screening multiple new molecular entities in recently initiated COVID-19 research program

Cash runway guidance extended into mid-2022

Conference Call and Webcast Scheduled Today at 8:45 AM ET

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News